SCHEMBL14224655

SCHEMBL14224655

CCC(=O)N[C@@H](CO)Cc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.65
CYP3A4 P08684 1/20 0.65
MME P08473 3/20 0.54
HPGD P15428 1/20 0.52
ROCK2 O75116 3/20 0.51
ROCK1 Q13464 3/20 0.51
RPS6KA5 O75582 1/20 0.51
RPS6KA4 O75676 1/20 0.51
PRKACA P17612 1/20 0.51
GSK3A P49840 1/20 0.51
GSK3B P49841 1/20 0.51
IRAK1 P51617 1/20 0.51
PRKX P51817 1/20 0.51
PRKG1 Q13976 1/20 0.51
PKN2 Q16513 1/20 0.51
CLK4 Q9HAZ1 1/20 0.51
SGK2 Q9HBY8 1/20 0.51
PARP1 P09874 1/20 0.49
PARP3 Q9Y6F1 1/20 0.49
NPC1 O15118 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12880450 1.00 MAPK1 (0.65) MAPK1CYP3A4MMEHPGDROCK2
SCHEMBL27803383 1.00 MAPK1 (0.65) MAPK1CYP3A4MMEHPGDROCK2
SCHEMBL4344248 0.88 MAPK1 (0.66) MAPK1CYP3A4MMEHPGDROCK2
SCHEMBL13502648 0.87 MAPK1 (0.61) MAPK1CYP3A4MMEHPGDROCK2
SCHEMBL22479796 0.85 MME (0.53) MAPK1CYP3A4MMEHPGDNPC1
SCHEMBL14376581 0.85 CNR1 (0.58) MAPK1CYP3A4LMNA
SCHEMBL9068996 0.85 MME (0.73) MAPK1CYP3A4MMEROCK2ROCK1
SCHEMBL27623676 0.84 CERT1 (0.59) MAPK1CYP3A4MMEHPGDPARP1
SCHEMBL8231536 0.84 MAPK1 (0.66) MAPK1CYP3A4MMEHPGDROCK2
SCHEMBL25159733 0.83 MAPK1 (0.60) MAPK1CYP3A4MMEROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012174407-A1 METHOD OF PRODUCING BERAPROST Lung LLC (US) 2012-12-20 WO disclosed
US-7354919-B2 Isoxazole compositions useful as inhibitors of ERK VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-08 US disclosed